BRIDGEBIO PHARMA INC.
25.95
08-十一月-24 10:47:44
15 分钟延时
股票
+0.07
+0.27%
今日范围
25.57 - 26.20
ISIN
N/A
来源
NASDAQ
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
04 8月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Second Quarter 2023 Financial Results and Business Update
03 8月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
18 7月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
17 7月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
14 7月 2023 16:01:00 条件 Nasdaq GlobeNewswire
-
12 7月 2023 16:31:00 条件 Nasdaq GlobeNewswire
-
20 6月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
13 6月 2023 09:33:35 条件 Nasdaq GlobeNewswire
-
15 5月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
11 5月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports First Quarter 2023 Financial Results and Business Update
04 5月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma to Participate in the Bank of America Merrill Lynch Global Healthcare Conference
27 4月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
11 4月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
07 4月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
23 3月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
21 3月 2023 07:30:00 条件 Nasdaq GlobeNewswire